Post

Vitestro’s robotic blood drawing device meets trial endpoints

Netherland-based Vitestro has announced positive results from a  trial evaluating the safety and efficacy of its autonomous blood-drawing device. The results …

SOTIO Biotech doses first subject in Phase I solid tumour treatment trial

SOTIO Biotech has dosed the first subject in its Phase I clinical trial VICTORIA-01 to assess the novel immunocytokine SOT201 …

IGC Pharma enrols two subjects in Alzheimer’s therapy trial at Neurostudies

IGC Pharma has reported the enrolment of two subjects at Neurostudies, a clinical research site in Port Charlotte, Florida, US, …

Ceretrieve touts positive data from aspiration catheter study

Ceretrieve has announced positive study results demonstrating that its aspiration catheter demonstrated clot removal, completely restoring blood flow in a …

Insmed stocks soar as Phase III lung disease drug exceeds expectations

Insmed’s stocks more than doubled after the company announced its lead-pipeline candidate brensocatib succeeded in a Phase III trial. The highly …